Related Articles
Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation
The androgen receptor in hormone-refractory prostate cancer: Relevance of different mechanisms of androgen receptor signaling (Review)
CRISPR/Cas9 targeting of the androgen receptor suppresses the growth of LNCaP human prostate cancer cells
Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor
Androgen receptor and soy isoflavones in prostate cancer (Review)